These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Differential glucose metabolism in mice and humans affected by McArdle disease. Krag TO; Pinós T; Nielsen TL; Duran J; García-Rocha M; Andreu AL; Vissing J Am J Physiol Regul Integr Comp Physiol; 2016 Aug; 311(2):R307-14. PubMed ID: 27280431 [TBL] [Abstract][Full Text] [Related]
5. Sodium valproate increases the brain isoform of glycogen phosphorylase: looking for a compensation mechanism in McArdle disease using a mouse primary skeletal-muscle culture in vitro. de Luna N; Brull A; Guiu JM; Lucia A; Martin MA; Arenas J; Martí R; Andreu AL; Pinós T Dis Model Mech; 2015 May; 8(5):467-72. PubMed ID: 25762569 [TBL] [Abstract][Full Text] [Related]
6. Systemic AAV8-mediated delivery of a functional copy of muscle glycogen phosphorylase (Pygm) ameliorates disease in a murine model of McArdle disease. McNamara EL; Taylor RL; Clayton JS; Goullee H; Dilworth KL; Pinós T; Brull A; Alexander IE; Lisowski L; Ravenscroft G; Laing NG; Nowak KJ Hum Mol Genet; 2020 Jan; 29(1):20-30. PubMed ID: 31511858 [TBL] [Abstract][Full Text] [Related]
7. Exercising with blocked muscle glycogenolysis: Adaptation in the McArdle mouse. Nielsen TL; Pinós T; Brull A; Vissing J; Krag TO Mol Genet Metab; 2018 Jan; 123(1):21-27. PubMed ID: 29174367 [TBL] [Abstract][Full Text] [Related]
8. Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease. Nogales-Gadea G; Pinós T; Lucia A; Arenas J; Camara Y; Brull A; de Luna N; Martín MA; Garcia-Arumí E; Martí R; Andreu AL Brain; 2012 Jul; 135(Pt 7):2048-57. PubMed ID: 22730558 [TBL] [Abstract][Full Text] [Related]
9. Muscle molecular adaptations to endurance exercise training are conditioned by glycogen availability: a proteomics-based analysis in the McArdle mouse model. Fiuza-Luces C; Santos-Lozano A; Llavero F; Campo R; Nogales-Gadea G; Díez-Bermejo J; Baladrón C; González-Murillo Á; Arenas J; Martín MA; Andreu AL; Pinós T; Gálvez BG; López JA; Vázquez J; Zugaza JL; Lucia A J Physiol; 2018 Mar; 596(6):1035-1061. PubMed ID: 29315579 [TBL] [Abstract][Full Text] [Related]
10. The effect of muscle glycogen phosphorylase (Pygm) knockdown on zebrafish morphology. Migocka-Patrzałek M; Lewicka A; Elias M; Daczewska M Int J Biochem Cell Biol; 2020 Jan; 118():105658. PubMed ID: 31747538 [TBL] [Abstract][Full Text] [Related]
11. Muscle diffusion tensor imaging in glycogen storage disease V (McArdle disease). Rehmann R; Schlaffke L; Froeling M; Kley RA; Kühnle E; De Marées M; Forsting J; Rohm M; Tegenthoff M; Schmidt-Wilcke T; Vorgerd M Eur Radiol; 2019 Jun; 29(6):3224-3232. PubMed ID: 30560358 [TBL] [Abstract][Full Text] [Related]
12. Muscle fiber type proportion and size is not altered in mcardle disease. Henning F; Cunninghame CA; Martín MA; Rubio JC; Arenas J; Lucia A; HernáNdez-Laín A; Kohn TA Muscle Nerve; 2017 Jun; 55(6):916-918. PubMed ID: 27859426 [TBL] [Abstract][Full Text] [Related]
13. McArdle Disease: New Insights into Its Underlying Molecular Mechanisms. Llavero F; Arrazola Sastre A; Luque Montoro M; Gálvez P; Lacerda HM; Parada LA; Zugaza JL Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775340 [TBL] [Abstract][Full Text] [Related]
14. Metabolic aspects of glycogenolysis with special attention to McArdle disease. Stefanik E; Dubińska-Magiera M; Lewandowski D; Daczewska M; Migocka-Patrzałek M Mol Genet Metab; 2024 Aug; 142(4):108532. PubMed ID: 39018613 [TBL] [Abstract][Full Text] [Related]
15. Investigating sodium valproate as a treatment for McArdle disease in sheep. Howell JM; Dunton E; Creed KE; Quinlivan R; Sewry C Neuromuscul Disord; 2015 Feb; 25(2):111-9. PubMed ID: 25455802 [TBL] [Abstract][Full Text] [Related]
16. Effect of Dipsaci radix on hind limb muscle atrophy of sciatic nerve transected rats. Jung HS; Noh CK; Ma SH; Hong EK; Sohn NW; Kim YB; Kim SH; Sohn Y Am J Chin Med; 2009; 37(6):1069-84. PubMed ID: 19938217 [TBL] [Abstract][Full Text] [Related]
17. Low aerobic capacity in McArdle disease: A role for mitochondrial network impairment? Villarreal-Salazar M; Santalla A; Real-Martínez A; Nogales-Gadea G; Valenzuela PL; Fiuza-Luces C; Andreu AL; Rodríguez-Aguilera JC; Martín MA; Arenas J; Vissing J; Lucia A; Krag TO; Pinós T Mol Metab; 2022 Dec; 66():101648. PubMed ID: 36455789 [TBL] [Abstract][Full Text] [Related]
20. Generation of the First Human In Vitro Model for McArdle Disease Based on iPSC Technology. Ortuño-Costela MDC; Cerrada V; Moreno-Izquierdo A; García-Consuegra I; Laberthonnière C; Delourme M; Garesse R; Arenas J; Fuster García C; García García G; Millán JM; Magdinier F; Gallardo ME Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]